← Back to Search

Speech breathing intervention for Shortness of Breath

N/A
Waitlist Available
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
Awards & highlights

Study Summary

This trial will test the feasibility and acceptability of a 4-week remote intervention for older speakers with phonatory dyspnea.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in reported dyspnea
Change in reported voice handicap
Secondary outcome measures
Acceptability of the intervention
Change in reported self-efficacy
Other outcome measures
Breath intake pattern

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment2 Interventions
This is a single-arm trial. All participants will receive (1) a control condition (socialization phase, 2 weeks) and (2) an intervention condition (speech breathing intervention, 4 weeks). Group sessions will take place once a week, and participants will be instructed to practice their exercises every day at home during the study duration.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Socialization phase
2021
N/A
~20
Speech breathing intervention
2021
N/A
~20

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
25,191 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025